<p>Coinfection of SARS-CoV-2 and influenza A virus changes neither the trajectory nor the severity of influenza A virus, regardless of timing. But if a person contracts influenza A virus first, the response to that infection can significantly suppress SARS-CoV-2, according to research.</p>.<p>"The research is important because the human population now has two circulating respiratory RNA viruses with high pandemic potential: SARS-CoV-2 and influenza A," said researchers from the New York University, Langone.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/opinion/second-edit/step-up-efforts-on-third-dose-of-covid-vaccine-1126108.html">Step up efforts on third dose of Covid vaccine</a></strong></p>.<p>"As both viruses infect the airways, and can result in significant morbidity and mortality, it is imperative that we also understand the consequences of coinfection," they added.</p>.<p>Several clinical studies had previously reported on co-infection of SARS-CoV-2 with other viruses.</p>.<p>These viruses infect the same cells within the airway.</p>.<p>Notably, the influenza A virus interferes with SARS-CoV-2 replication in the lung and can continue to do so even more than one week after clearance of influenza A, according to the research published in the Journal of Virology.</p>.<p>"These data suggest the presence of factors intrinsic to or induced by (influenza A virus) that may restrict the growth of SARS-CoV-2, but it remains unclear whether this effect plays a role on disease severity," the researchers wrote.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/national/india-logs-16906-new-covid-19-cases-up-24-from-a-day-ago-1126198.html">India logs 16,906 new Covid-19 cases, up 24% from a day ago</a></strong></p>.<p>The investigators performed the experiments in cultured cells, as well as in a golden hamster animal model. "Animals were administered the 2 viruses simultaneously, and examined at days 1,3, 5, 7 and 14 post-infection," said corresponding author Benjamin R tenOever, Professor of microbiology, at NYU.</p>.<p>The researchers also conducted experiments in which they first challenged the animals with either virus, followed three days later by the other virus, monitoring (them) on days 1, 3, and 5 post-second challenge.</p>.<p>"This study could be used as an example of how an immune response to something unrelated can provide protection against SARS-CoV-2," said tenOever.</p>.<p>The team demonstrated that coinfection does not result in a worse outcome of disease in an animal model. These results suggest that coinfection with SARS-CoV-2 and influenza A virus does not represent a looming threat for humanity," said tenOever.</p>
<p>Coinfection of SARS-CoV-2 and influenza A virus changes neither the trajectory nor the severity of influenza A virus, regardless of timing. But if a person contracts influenza A virus first, the response to that infection can significantly suppress SARS-CoV-2, according to research.</p>.<p>"The research is important because the human population now has two circulating respiratory RNA viruses with high pandemic potential: SARS-CoV-2 and influenza A," said researchers from the New York University, Langone.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/opinion/second-edit/step-up-efforts-on-third-dose-of-covid-vaccine-1126108.html">Step up efforts on third dose of Covid vaccine</a></strong></p>.<p>"As both viruses infect the airways, and can result in significant morbidity and mortality, it is imperative that we also understand the consequences of coinfection," they added.</p>.<p>Several clinical studies had previously reported on co-infection of SARS-CoV-2 with other viruses.</p>.<p>These viruses infect the same cells within the airway.</p>.<p>Notably, the influenza A virus interferes with SARS-CoV-2 replication in the lung and can continue to do so even more than one week after clearance of influenza A, according to the research published in the Journal of Virology.</p>.<p>"These data suggest the presence of factors intrinsic to or induced by (influenza A virus) that may restrict the growth of SARS-CoV-2, but it remains unclear whether this effect plays a role on disease severity," the researchers wrote.</p>.<p><strong>Also Read | <a href="https://www.deccanherald.com/national/india-logs-16906-new-covid-19-cases-up-24-from-a-day-ago-1126198.html">India logs 16,906 new Covid-19 cases, up 24% from a day ago</a></strong></p>.<p>The investigators performed the experiments in cultured cells, as well as in a golden hamster animal model. "Animals were administered the 2 viruses simultaneously, and examined at days 1,3, 5, 7 and 14 post-infection," said corresponding author Benjamin R tenOever, Professor of microbiology, at NYU.</p>.<p>The researchers also conducted experiments in which they first challenged the animals with either virus, followed three days later by the other virus, monitoring (them) on days 1, 3, and 5 post-second challenge.</p>.<p>"This study could be used as an example of how an immune response to something unrelated can provide protection against SARS-CoV-2," said tenOever.</p>.<p>The team demonstrated that coinfection does not result in a worse outcome of disease in an animal model. These results suggest that coinfection with SARS-CoV-2 and influenza A virus does not represent a looming threat for humanity," said tenOever.</p>